Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China

• Asıl Yazarlar: Min Li (Yazar), Yuxin Cao (Yazar), Hao Huang (Yazar), Gang Qin (Yazar), Minjie Chu (Yazar), Meiyin Zou (Yazar), Xun Zhuang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2023-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Introduction Dolutegravir (DTG)-based regimen was included in the expanded formulary of China's National Free Antiretroviral Treatment Program at the end of 2021. Yet high price of DTG and lack of health economic evaluation in China present barriers for implementation of the regimen. T...